top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

Martin Wygod Biography and Net Worth

Director of Forian

Founder of Forian, Inc. and Medical Outcomes Research Analysis LLC, Max C. Wygod is Executive Chairman at Forian, Inc. and Executive Chairman at Medical Outcomes Research Analysis LLC (a subsidiary of Forian, Inc.).

He previously was Vice President-Business Development of WebMD Health Corp.

Max C. Wygod received an undergraduate degree from Duke University and an MBA from The Leonard N Stern School of Business.

What is Martin J. Wygod's net worth?: The estimated net worth of Martin J. Wygod is at least $163,235.80 as of October 4th, 2023. Mr. Wygod owns 62,783 shares of Forian stock worth more than $163,236 as of April 25th. This net worth approximation does not reflect any other assets that Mr. Wygod may own. Learn More about Martin J. Wygod's net worth.
How do I contact Martin J. Wygod?: The corporate mailing address for Mr. Wygod and other Forian executives is 41 University Drive, Suite 400, Newtown, PA 18940, United States. Forian can also be reached via phone at +17203285372. Learn More on Martin J. Wygod's contact information.
Has Martin J. Wygod been buying or selling shares of Forian?: Martin J. Wygod has not been actively trading shares of Forian over the course of the past ninety days. Most recently, on Wednesday, October 4th, Martin J. Wygod bought 1,700 shares of Forian stock. The stock was acquired at an average cost of $2.38 per share, with a total value of $4,046.00. Following the completion of the transaction, the director now directly owns 62,783 shares of the company's stock, valued at $149,423.54. Learn More on Martin J. Wygod's trading history.
Who are Forian's active insiders?: Forian's insider roster includes Jennifer Hajj (Director), Stanley Trotman, Jr. (Director), and Martin Wygod (Director). Learn More on Forian's active insiders.
Are insiders buying or selling shares of Forian?: During the last twelve months, Forian insiders bought shares 6 times. They purchased a total of 28,365 shares worth more than $67,097.53. The most recent insider tranaction occured on October, 4th when Director Martin J Wygod bought 1,700 shares worth more than $4,046.00. Insiders at Forian own 31.3% of the company. Learn More about insider trades at Forian.
Information on this page was last updated on 10/4/2023.

Martin J. Wygod Insider Trading History at Forian

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/4/2023	Buy	1,700	$2.38	$4,046.00	62,783
5/30/2023	Buy	4,565	$2.39	$10,910.35	56,294
5/25/2023	Buy	3,000	$2.34	$7,020.00	51,729
5/23/2023	Buy	5,999	$2.38	$14,277.62	47,402
5/18/2023	Buy	5,444	$2.29	$12,466.76	41,403
2/14/2023	Buy	10,485	$3.91	$40,996.35	35,959
4/13/2022	Buy	2,030	$4.67	$9,480.10	22,324
4/11/2022	Buy	3,059	$5.02	$15,356.18	14,261
4/6/2022	Buy	202	$5.41	$1,092.82	11,202
4/4/2022	Buy	3,000	$6.46	$19,380.00	3,000
4/1/2022	Buy	6,827	$6.68	$45,604.36
3/30/2022	Buy	800	$6.75	$5,400.00
3/28/2022	Buy	3,200	$6.41	$20,512.00
2/14/2022	Buy	4,800	$7.66	$36,768.00
2/10/2022	Buy	4,800	$7.92	$38,016.00
1/21/2022	Buy	1,600	$8.01	$12,816.00
1/10/2022	Buy	3,200	$7.81	$24,992.00
12/15/2021	Buy	1,654	$7.81	$12,917.74
12/13/2021	Buy	6,678	$7.94	$53,023.32
12/10/2021	Buy	30	$8.04	$241.20
12/6/2021	Buy	6	$8.14	$48.84
12/3/2021	Buy	8,000	$8.10	$64,800.00
11/22/2021	Buy	455	$9.20	$4,186.00
11/17/2021	Buy	4,811	$9.83	$47,292.13
10/14/2021	Buy	9,002	$10.04	$90,380.08
10/5/2021	Buy	700	$10.08	$7,056.00
9/15/2021	Buy	7,844	$9.94	$77,969.36
9/13/2021	Buy	4,000	$10.00	$40,000.00
6/1/2021	Buy	1,300	$9.95	$12,935.00
5/25/2021	Buy	6,414	$9.97	$63,947.58
5/21/2021	Buy	8,000	$9.95	$79,600.00
5/19/2021	Buy	5,000	$9.94	$49,700.00

Martin J. Wygod Buying and Selling Activity at Forian

Forian Company Overview

Forian Inc. provides software and information solutions, proprietary data driven insights, and predictive analytics to optimize and measure the operational, clinical, and financial performance of its life science and healthcare customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides customers with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; and BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain. In addition, the company offers security monitoring and web marketing services. Forian Inc. was incorporated in 2020 and is headquartered in Newtown, Pennsylvania. Forian Inc.

Today's Range

Now: $2.64

$2.64

50 Day Range

MA: $2.96

$2.46

$3.64

2 Week Range

Now: $2.64

$1.85

$4.15

Volume

282 shs

Average Volume

26,344 shs

Market Capitalization

$82.19 million

P/E Ratio

8.00

Dividend Yield

N/A

Beta

1.03